Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial
| Title: | Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial |
|---|---|
| Authors: | Aygun, Banu *, Lane, Adam, Smart, Luke R, Santos, Brígida, Tshilolo, Léon, Williams, Thomas N, Olupot-Olupot, Peter, Stuber, Susan E, Tomlinson, George, Latham, Teresa, Ware, Russell E |
| Source: | In The Lancet Haematology June 2024 11(6):e425-e435 |
| Database: | ScienceDirect |
Be the first to leave a comment!